The Blue Box Biomedical Solutions

Startup
  • Location

    Hall 8.1 - 4YFN Stand 8.1C23.7A

Information

Breast cancer is the most treatable cancer, yet it remains the leading cause of death by cancer in women—largely because national screening programs miss up to 1 in 3 cases. The problem is even worse for women with dense breasts, who make up 50% of the screening population and for whom mammography is less reliable. At The Blue Box, we've developed a urine-based breast cancer test with a sensitivity of 88.42%, outperforming mammography by 15% overall—and by 30% in women with dense breasts.

Key Information

  • Growth Stage
    Seed
  • Country
    Spain
  • Founding Year
    2021